Turning Ranbaxy Around

Celltrion updates strategy for potential Trump reciprocal tariffs on pharmaceuticals

Biopharma groups seek changes to FDA’s innovative manufacturing strategy

Sanofi CD38 antibody delivers in phase 3 trial

Pfizer to let go of 791 employees at NJ site